Advancements in blood testing and science in the last 5 years….
The last five years have seen major advances in blood testing and related scientific breakthroughs, dramatically improving early detection, speed, accuracy, and disease monitoring across medicine.
Key Innovations
Liquid Biopsies: Non-invasive tests now routinely scan blood for cancer DNA, enabling early cancer diagnosis and personalized treatment plans, even identifying types previously only found through surgery.
Alzheimer’s and Neurodegenerative Disease: Next-generation blood tests measuring novel tau and amyloid biomarkers (such as MTBR-tau243) can diagnose Alzheimer’s earlier, gauge disease progression, and target therapy—reducing reliance on costly brain scans.
Single-Cell Sequencing for Blood Cancers: The SWIFT-seq test for multiple myeloma isolates and profiles circulating tumor cells directly from blood samples, surpassing traditional bone marrow diagnostic accuracy while offering risk assessment and disease monitoring.
Rapid, Low-Cost Point-of-Care Diagnostics: New devices such as NasRED detect diseases (COVID-19, AIDS, Lyme disease, Ebola) in under 15 minutes from a single drop of blood. These can be deployed in clinics, homes, or remote areas and cost just a few dollars.
Mass Spectrometry & Omics: Automation and integration of mass spectrometry, genomics, and multi-omics platforms enable even faster, more sensitive routine blood tests, facilitating precision medicine and individualized therapies for many conditions.
Trends Shaping Blood Science
Genetic and Biomarker Testing: A sharp rise in analysis of DNA, proteins, and metabolites in blood is transforming diagnostics and personalized medicine through “omics” technologies.
Patient Blood Management: Improved viscoelastic blood testing at point-of-care reduces unnecessary transfusions and avoids complications, responding to global blood shortages.
Miniaturization and Home Testing: Kits with embedded artificial intelligence are expanding reliable lab-quality blood analysis to home care and small clinics, reducing dependency on centralized labs.
Early Detection of Hard-to-Catch Diseases: Emerging blood tests for pancreatic cancer, myeloma, and Alzheimer’s offer markedly earlier—and sometimes pre-symptomatic—detection, which improves survival odds.
Notable Examples (2020–2025)
PrecivityAD2™: Next-gen Alzheimer’s blood test measuring amyloid-beta and tau proteins for more precise diagnoses.
SWIFT-seq: Single-cell sequencing of tumor cells for myeloma risk assessment from blood.
NasRED Device: Rapid disease detection for infectious illnesses from one blood drop.
Protease-Based Pancreatic Cancer Test: Early screening method using blood proteins for detection.
Automated Mass Spectrometry Workflows: Faster, high-sensitivity screening for a range of diseases with less skilled labor needed.
These advancements collectively make blood tests faster, less invasive, more accurate, and more affordable, greatly expanding their role in healthcare and disease prevention.
Sent from my phone with Blog This WOW